(Q48141180)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

23 February 2020

main subject

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Steen B. Pedersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Niels Jessen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sara Heebøll

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Ylva Erika Kristina Hellberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David Haldrup

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lars Porskjaer Christensen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Henning Grønbaek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

1 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

668-675

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

23 February 2020

cites work

1 reference

Are sirtuins viable targets for improving healthspan and lifespan?

21 January 2018

1 reference

Effects of resveratrol and other polyphenols in hepatic steatosis.

21 January 2018

1 reference

Evolving aspects of liver transplantation for nonalcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease in Asia: a story of growth

21 January 2018

1 reference

Extrahepatic complications of nonalcoholic fatty liver disease

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Effect of resveratrol on experimental non-alcoholic steatohepatitis.

21 January 2018

1 reference

Resveratrol inhibits nonalcoholic fatty liver disease in rats

21 January 2018

1 reference

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

21 January 2018

1 reference

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

21 January 2018

1 reference

Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning

21 January 2018

1 reference

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

21 January 2018

1 reference

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

21 January 2018

1 reference

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

21 January 2018

1 reference

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

21 January 2018

1 reference

Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.

21 January 2018

1 reference

Dose translation from animal to human studies revisited

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

21 January 2018

1 reference

Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies

21 January 2018

1 reference

Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion?

21 January 2018

1 reference

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes

21 January 2018

1 reference

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

Safety studies conducted on high-purity trans-resveratrol in experimental animals.

21 January 2018

1 reference

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26312773%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference